This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Fracture of the triquetral

Authoring team

The triquetrum is the second most commonly fractured carpal bone, comprising 15–18% of all carpal bone fractures. The triquetral bone may be fractured by violent hyperextension of the wrist and fractures are more commonly caused by impaction by adjacent bony structures or avulsion of attached ligaments rather than a direct blow, as the surrounding carpal bones protect the triquetrum from direct impact.

Radiography provides the diagnosis although there is no single best view for detecting all variants of triquetral fractures and multiple radiographs should be evaluated together.

Triquetral fractures can be treated satisfactorily with analgesia and immobilization in most cases. They respond favourably to immobilization for 4–6 weeks as they become an asymptomatic fibrous union. In this way, most triquetral fractures are well tolerated even without a true bony union.

Surgical treatment should be considered for fractures with significant displacement or those associated with fracture dislocation concerning for instability.

Reference

  1. Guo R et al. Triquetral Fractures Overview. Curr Rev Musculoskelet Med. 2021 Jan 23;14(2):101–106.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2026 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.